| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |